Wird geladen...
Re-Assessing PK/PD Issues for Oral Protein and Peptide Delivery
Due to a lack of safe and effective oral delivery strategies for most protein and peptide therapeutics, pharmaceutical drug developers have focused on parenteral routes to administer these agents. Recent advances in delivery technologies have now shown clinical validation for a few of these biopharm...
Gespeichert in:
| Veröffentlicht in: | Pharmaceutics |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8309183/ https://ncbi.nlm.nih.gov/pubmed/34371698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13071006 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|